Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemia (Q37296134)

From Wikidata
Jump to navigation Jump to search
scientific article published on 02 September 2013
edit
Language Label Description Also known as
English
Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemia
scientific article published on 02 September 2013

    Statements

    Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemia (English)
    Lisa Triche
    Deborah Thomas
    2 September 2013
    369-372

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit